Search

Home > GRACEcast Lung Cancer Video > Could BRAF be a new target in NSCLC?
Podcast: GRACEcast Lung Cancer Video
Episode:

Could BRAF be a new target in NSCLC?
Category: Science & Medicine
Duration: 00:04:57
Publish Date: 2013-06-27 08:04:25
Description:

Drs. Nate Pennell, Mary Pinder, and Jack West discuss an encouraging study of dabrafenib, a BRAF inhibitor, for the limited number of NSCLC patients with a BRAF V600E mutation.
Total Play: 0